The Patent Finder

Modulation of Signal Transducer and Activator of Transcription 3 (STAT3) Expression

Isis Pharmaceuticals, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,479,993Modulation of Signal Transducer and Activator of Transcription 3 (STAT3) Expression
In force
 · Low confidence
Ionis Pharmaceutials, Inc.In force
Low confidence
US 8,816,056Modulation of Signal Transducer and Activator of Transcription 3 (STAT3)EXPRESSION
In force
 · High confidence
Ionis Pharmaceuticals, Inc.In force
High confidence
US 9,359,608Modulation of Signal Transducer and Activator of Transcription 3 (STAT3) Expression
In force
 · High confidence
Isis Pharmaceuticals, Inc.In force
High confidence
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Isis Pharmaceuticals, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited